Latest Breaking News On - செல் விண்கலம் - Page 1 : comparemela.com
All aboard the Cell Shuttle: Cellares cell therapy factory-in-a-box project attracts a 3rd partner in Poseida
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy Manufacturing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
New Fund for Early-Stage Life Sciences, Microscopy for Protein Dynamics: Follow the Money
bio-itworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bio-itworld.com Daily Mail and Mail on Sunday newspapers.
May 6, 2021 8:15am
Cellares has now received a total of $100 million in funding to develop its cell therapy factory-in-a-box. (Cellares Corporation)
As cell therapies take the cancer world by storm, drugmakers are on the prowl for the latest and greatest ways to produce the complex medicines. Life sciences technology firm Cellares thinks the answer could fit in a box a factory-in-a-box, to be precise and the company just raised $82 million to take that work to the next level.
Armed with a fresh series B, Cellares now has $100 million in total funding to develop the Cell Shuttle a modular, end-to-end cell therapy factory that leverages automation to take in patients cells, re-engineer them and quickly turn out a finished product ready for infusion.
MedCity News
Cellares gets $82M to make cell therapy manufacturing automated, scalable
Cell therapy manufacturing is currently a manual, multi-step process that takes weeks. Startup Cellares, which is developing a system that automates the process and makes manufacturing scalable, will use the Series B financing to accelerate its work.
Shares0
Talk to enough biotech industry folks and the phrase “the product is the process” is bound to come up. It refers to cell therapies, which are made by engineering human cells. In short, the medicine is an extension of the process that produced it. Today, that process is time consuming, mostly manual, and very expensive.